BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15474630)

  • 21. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality.
    Weinberger M; Leibovici L; Perez S; Samra Z; Ostfeld I; Levi I; Bash E; Turner D; Goldschmied-Reouven A; Regev-Yochay G; Pitlik SD; Keller N
    J Hosp Infect; 2005 Oct; 61(2):146-54. PubMed ID: 16009456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed fungemia: incidence, risk factors, and mortality in a general hospital.
    Jensen J; Muñoz P; Guinea J; Rodríguez-Créixems M; Peláez T; Bouza E
    Clin Infect Dis; 2007 Jun; 44(12):e109-14. PubMed ID: 17516389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candida glabrata fungemia: experience in a tertiary care center.
    Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA
    Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and outcome for nosocomial breakthrough candidaemia.
    Pasqualotto AC; Nedel WL; Machado TS; Severo LC
    J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia.
    Tumbarello M; Posteraro B; Trecarichi EM; Fiori B; Rossi M; Porta R; de Gaetano Donati K; La Sorda M; Spanu T; Fadda G; Cauda R; Sanguinetti M
    J Clin Microbiol; 2007 Jun; 45(6):1843-50. PubMed ID: 17460052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution.
    Abelson JA; Moore T; Bruckner D; Deville J; Nielsen K
    Pediatrics; 2005 Jul; 116(1):61-7. PubMed ID: 15995032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
    Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
    Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethnicity and other possible risk factors for candidemia at 3 tertiary care university hospitals in Hawaii.
    Fujitani S; Ricardo-Dukelow M; Kamiya T; Sullivan L; Low L
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1261-3. PubMed ID: 17080389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections.
    Asmundsdóttir LR; Erlendsdóttir H; Haraldsson G; Guo H; Xu J; Gottfredsson M
    Clin Infect Dis; 2008 Jul; 47(2):e17-24. PubMed ID: 18549311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candida glabrata fungaemia in intensive care units.
    Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species.
    Cheng MF; Yang YL; Yao TJ; Lin CY; Liu JS; Tang RB; Yu KW; Fan YH; Hsieh KS; Ho M; Lo HJ
    BMC Infect Dis; 2005 Apr; 5():22. PubMed ID: 15813977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nosocomial candidaemia in children: results of a 9-year study.
    Celebi S; Hacimustafaoglu M; Ozdemir O; Ozkaya G
    Mycoses; 2008 May; 51(3):248-57. PubMed ID: 18399906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults.
    McMullan R; Metwally L; Coyle PV; Hedderwick S; McCloskey B; O'Neill HJ; Patterson CC; Thompson G; Webb CH; Hay RJ
    Clin Infect Dis; 2008 Mar; 46(6):890-6. PubMed ID: 18260751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of community-onset candidemia in Connecticut and Maryland.
    Sofair AN; Lyon GM; Huie-White S; Reiss E; Harrison LH; Sanza LT; Arthington-Skaggs BA; Fridkin SK
    Clin Infect Dis; 2006 Jul; 43(1):32-9. PubMed ID: 16758415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida colonization and candidemia in a pediatric intensive care unit.
    Singhi S; Rao DS; Chakrabarti A
    Pediatr Crit Care Med; 2008 Jan; 9(1):91-5. PubMed ID: 18477920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of candidemia in intensive care units.
    Bouza E; Muñoz P
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
    Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
    Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.